M. Redrado

发表

Differential tumor expression of inhibitor of differentiation-1 in prostate cancer patients with extreme clinical phenotypes and prognostic implications.

M. Ponz-Sarvisé, E. Castañón, Á. Panizo-Santos, 2014, Clinical genitourinary cancer.

Cyclophosphamide for Metastatic Cancer Combined with GM-CSF, Pegylated IFN, and Loaded with Autologous Tumor Lysates Pilot Clinical Trial of Type 1 Dendritic Cells

B. Sangro, I. Melero, S. Martín-Algarra, 2011 .

Pilot Clinical Trial of Type 1 Dendritic Cells Loaded with Autologous Tumor Lysates Combined with GM-CSF, Pegylated IFN, and Cyclophosphamide for Metastatic Cancer Patients

B. Sangro, I. Melero, S. Martín-Algarra, 2011, The Journal of Immunology.

The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche.

C. Rolfo, L. Raez, E. Castañón, 2017, Cancer letters.

TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.

M. Pajares, M. Redrado, A. Calvo, 2016, Cancer letters.

Co-migration of colon cancer cells and CAFs induced by TGFβ1 enhances liver metastasis

M. Redrado, A. Calvo, I. Manrique, 2015, Cell and Tissue Research.

New syngeneic inflammatory‐related lung cancer metastatic model harboring double KRAS/WWOX alterations

F. Lecanda, M. Pajares, M. Redrado, 2014, International journal of cancer.

TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients

I. Wistuba, C. Behrens, M. Pajares, 2019, Journal of clinical medicine.

Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts

F. Bertolini, C. Prior, M. Redrado, 2012, Laboratory Investigation.

Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144.

M. Redrado, A. Calvo, F. Vidal-Vanaclocha, 2013, Experimental cell research.

Therapeutic Effect of Lenalidomide in a Novel Xenograft Mouse Model of Human Blastic NK Cell Lymphoma/Blastic Plasmacytoid Dendritic Cell Neoplasm

F. Bertolini, C. Prior, M. Redrado, 2011, Clinical Cancer Research.

Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity

P. Allavena, A. Mantovani, Clément Anfray, 2021, Journal for ImmunoTherapy of Cancer.

The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer

D. Sherris, M. Redrado, A. Calvo, 2009, British Journal of Cancer.

Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade

S. Vicent, F. Lecanda, J. Pérez-Gracia, 2020, Nature Cancer.

Sunitinib reduces tumor hypoxia and angiogenesis, and radiosensitizes prostate cancer stem‐like cells

M. Redrado, A. Calvo, P. Nguewa, 2015, The Prostate.

Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery.

S. Vicent, E. Guruceaga, M. Redrado, 2019, Cancer letters.

Co-migration of colon cancer cells and CAFs induced by TGFβ1 enhances liver metastasis

M. Redrado, A. Calvo, I. Manrique, 2015, Cell and Tissue Research.

miR-146a targets c-met and abolishes colorectal cancer liver metastasis.

M. Redrado, A. Calvo, J. Gómez-Román, 2018, Cancer letters.

Differential Effects of Drugs Targeting Cancer Stem Cell (CSC) and Non-CSC Populations on Lung Primary Tumors and Metastasis

W. Seeger, R. Savai, M. Redrado, 2013, PloS one.

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation

J. Lasarte, M. Redrado, A. Calvo, 2021, Journal for ImmunoTherapy of Cancer.

Id-1B, an alternatively spliced isoform of the inhibitor of differentiation-1, impairs cancer cell malignancy through inhibition of proliferation and angiogenesis.

C. Perez-stable, M. Redrado, A. Calvo, 2014, Current molecular medicine.

Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1

R. López-López, M. Pajares, D. Hervás, 2019, Scientific Reports.

Selenoprotein‐P is down‐regulated in prostate cancer, which results in lack of protection against oxidative damage

F. Milagro, L. Schomburg, Yoshiro Saito, 2011, The Prostate.

Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib

M. Redrado, A. Calvo, J. Capdevila, 2018, Oncotarget.

Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model

Irene Manrique, C. Perez-stable, M. Redrado, 2010, BMC Cancer.

TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis

M. Redrado, A. Calvo, L. Montuenga, 2014, British Journal of Cancer.

Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402).

E. Espinosa, M. Redrado, D. Rodríguez-Abreu, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance

I. Wistuba, C. Behrens, J. García-Foncillas, 2011, Clinical Cancer Research.

Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients

M. Esteller, M. Pajares, J. Sandoval, 2016, Oncotarget.

Sphere-derived tumor cells exhibit impaired metastasis by a host-mediated quiescent phenotype

F. Lecanda, M. Redrado, A. Calvo, 2015, Oncotarget.

Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma

Roman K. Thomas, I. Melero, M. Larrayoz, 2021, Disease Models & Mechanisms.

Circulating Levels of the Interferon-γ-Regulated Chemokines CXCL10/CXCL11, IL-6 and HGF Predict Outcome in Metastatic Renal Cell Carcinoma Patients Treated with Antiangiogenic Therapy

E. Esteban, J. Lambea, Jorge A. Garcia, 2021, Cancers.

Development of biological tools to assess the role of TMPRSS4 and identification of novel tumor types with high expression of this prometastatic protein.

M. Redrado, A. Calvo, L. Montuenga, 2017, Histology and Histopathology.

Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1.

R. López-López, M. Pajares, D. Hervás, 2019 .

TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.

M. Pajares, M. Redrado, A. Calvo, 2016, Cancer letters.

PTEN loss confers resistance to anti-PD-1 therapy in non-small cell lung cancer by increasing tumor infiltration of regulatory T cells.

K. Politi, E. Felip, L. Paz-Ares, 2023, Cancer research.

TITLE PAGE Title: Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance

C. Behrens, J. García-Foncillas, M. Pajares, 2011 .